ORPHA:200
Isolated corpus callosum agenesis
Publications
50,466
Trials
2
Interventional, condition-specific
Researchers
1,323
Distinct authors in sample
Gene link
CDK5RAP2, PAK3, ZEB1
Definitive
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare non-syndromic cerebral characterized by partial or complete absence of the corpus callosum. Patients are often asymptomatic but may also present with , visual impairment, delayed speech development, , feeding difficulties, impaired hand-eye coordination, and behavioral abnormalities. Patients may have a normal intelligence quotient while exhibiting specific cognitive deficits, such as reduced interhemispheric transfer of sensorimotor information, reduced cognitive processing speed, and deficits in complex reasoning and novel problem-solving.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0026419
- MONDO:0009022
- MeSH:D061085
- OMIM:217990
- UMLS:C0175754
- NCIT:C98905
Additional Mondo synonyms (3)
agenesis of corpus callosum · corpus callosum agenesis · corpus callosum, agenesis of
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — CDK5RAP2, PAK3, ZEB1
- LiteraturePresent
50,466 matched papers (36,034 in last 10 years) Source
- Phenotype characterisedPresent
23 HPO annotations (e.g. Camptodactyly; Microcephaly; Preauricular skin tag) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
2 matched on ClinicalTrials.gov
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (CDK5RAP2, PAK3, ZEB1).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
23
Associated phenotypes · MONDO:0026419
- Camptodactyly
- Microcephaly
- Preauricular skin tag
- Joint contracture of the hand
- Agenesis of corpus callosum
Showing 5 of 23 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
50,466
50,466 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
50,466 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
36,034 in the last 10 years · low confidence
Phrase hits: 11,542 · MeSH hits: 0
Who's working on it?
1,323
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Kasprian G5 papers · 2026
Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
Papers in Europe PMC - 02Romaniello R5 papers · 2025
Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Via Mondino 2, 27100, Pavia, Italy. Romina.romaniello@mondino.it.
Papers in Europe PMC - 03Li J4 papers · 2026
Prenatal Diagnosis Center, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Papers in Europe PMC - 04Pasca L4 papers · 2025
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Papers in Europe PMC - 05Paul LK4 papers · 2026
Travis Research Institute, Fuller School of Psychology & Marriage and Family Therapy, Pasadena, CA, USA.
Papers in Europe PMC - 06Wang X4 papers · 2026
Department of Radiology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Maternal and Child Health Care Hospital, Beijing, China.
Papers in Europe PMC - 07Agarwal S3 papers · 2026
Division of Neurology & Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Division of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Papers in Europe PMC - 08Borgatti R3 papers · 2025
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Papers in Europe PMC - 09Brown WS3 papers · 2026
Travis Research Institute, Fuller School of Psychology & Marriage and Family Therapy, Pasadena, CA, USA.
Papers in Europe PMC - 10De Giorgis V3 papers · 2026
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; IRCCS Mondino Foundation, Pavia, Italy, Member of the ERN EpiCARE. Electronic address: valentina.degiorgis@mondino.it.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; none in our sample are currently recruiting.
Data as of 11 September 2026 · last trial check 28 July 2026
2 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 84.5th percentile).
low confidence · 84.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
No currently recruiting studies in the matched set. Open the same search on ClinicalTrials.gov.
Observational and natural-history studies
4 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Isolated corpus callosum agenesis — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Isolated corpus callosum agenesis" OR "agenesis of corpus callosum" OR "agenesis of the corpus callosum" OR "corpus callosum agenesis" OR "corpus callosum, agenesis of") OR ("CDK5RAP2" OR "CDK5RAP2 syndrome" OR "CDK5RAP2-related" OR "PAK3" OR "PAK3 syndrome" OR "PAK3-related" OR "ZEB1" OR "ZEB1 syndrome" OR "ZEB1-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Isolated corpus callosum agenesis" OR "agenesis of corpus callosum" OR "agenesis of the corpus callosum" OR "corpus callosum agenesis" OR "corpus callosum, agenesis of"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 4 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (50466) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T12:52:54.392Z
